Nav: Home

Partners play critical role in melanoma exams

December 14, 2016

Having to strip down regularly to have your partner check for mole irregularities may be initially embarrassing to a person -- especially a woman -- previously diagnosed with melanoma.

But a new Northwestern Medicine study shows the benefits of a partner frequently checking for troublesome moles based on training to do so far outweigh the embarrassment.

Study participants who received skin examination training caught far more mole irregularities than those in the control group. They also grew more confident performing the examinations.

Common places to develop potentially fatal melanoma include hard-to-see areas where it is difficult to apply sunscreen such as behind the ears and knees, the top of the head and around the swimsuit line on a woman's bottom.

"These aren't parts of the body that most females like to have examined by their male partner, but at some point, they realized they're just looking at the moles, not the cellulite," said lead author Dr. June Robinson, research professor of dermatology at Northwestern University Feinberg School of Medicine. "We found as long as the benefit is strong enough, it overcomes whatever potential embarrassment there might be between the partners."

Partners of patients who had been previously diagnosed with early stages of melanoma performed frequent skin self-self examinations (SSEs) on the patient over the course of the two-year study.

As the study progressed, a partners' confidence in his or her ability to find irregular moles increased, as did the trust in one another to successfully identify the irregularities.

The study was published today (Dec. 14) in JAMA Dermatology.

Participants were asked every four months to indicate on a five-point scale how much they agreed or disagreed with the following two statements: "It is very embarrassing to have my partner help examine my skin," and "I am very comfortable having my partner help examine my skin."

Based on their responses, melanoma patients and their partners eventually had no problems being checked for irregular moles by their partners, Robinson said.

"In that discussion back and forth, they make a judgment call and agree on it," said Robinson, who is the editor of JAMA Dermatology. "As they each grow more confident in their decision-making, the trust between them becomes stronger. When the trust is there, there's no issue with embarrassment."

Also noteworthy, the study found mole observations men and women make complement one another. Men tend to notice mole border irregularities better than women, whereas women tend to see color variations in the moles better than men.

"The pairs realize, 'We need to help each other here,'" Robinson said. "If he sees borders better and she sees colors better, those two heads are better than one when finding the irregularities."

The 395 participants in the study had previously been diagnosed with early stages of melanoma (0 to IIB) and had surgically removed irregular moles. They were recruited from outpatient clinics of the Northwestern Medicine and were 21 to 80 years old.

The control group consisted of 99 participants who did not receive SSE training. The remaining participants received training in one of three forms: from a physician, by reading a take-home handbook or by listening to exercises on a tablet. The pairs performed SSEs on one another every month or every other month to check for mole irregularities, and assigned a score to common features of the mole: 1 if the mole looked normal, 2 if they were unsure and 3 if it looked abnormal.

Robinson's study received a four-year renewal, allowing her to continue following the participants and checking in every four months on their progress and levels of embarrassment, comfort and confidence with partner-assisted SSEs.
-end-
The study was supported by grant R01 CA154908 from the National Cancer Institute of the National Institutes of Health.

Northwestern University

Related Melanoma Articles:

B cells linked to immunotherapy for melanoma
Immunotherapy uses our body's own immune system to fight cancer.
Five things to know about melanoma
'Five things to know about ... melanoma' in CMAJ (Canadian Medical Association Journal) provides a brief overview of this malignant skin cancer for physicians and patients.
Describing aspects of melanoma progression
Three related articles and an editorial focus on various aspects of melanoma progression.
Is your melanoma hot enough for immunotherapy?
University of Colorado Cancer Center study presented at AACR 2019 shows that tumors with mutations in genes leading to over-activation of the NF-kB signaling pathway were more than three times as likely to respond to anti-PD1 immunotherapy compared with tumors in which these changes were absent.
BU researchers discover therapeutic target of melanoma
Researchers have identified a biomarker and a possible new therapy for melanoma.
More Melanoma News and Melanoma Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...